description
Powered by Eupheria Biotech
Quality Level
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
GACACAAGGGAAGGGTCAGAAACTTTGTGAAATTGAAAGGATACATTTCTTTCTGAGTAAGAAAAAACCAGATGAACTTAGAAATCTACACAAACTGCTTTACAACAGGCCGGGCACAGTGTCCTCGTTGAAGAAGAACGTGGGTCAGTTCAGTGGCTTTCCATTCGAAAAAGGCAGTACCCAGTATAAAAAGAAGGAAGAAATGTTGAAAAAGTTTCGAAATGCCATGTTAAAGAGCATCTGTGAGGTTCTTGATTTAGAGAGGTCAGGCGTGAACAGCGAACTCGTGAAGAGGATCTTGAACTTCTTAATGCATCCAAAGCCTTCTGGCAAACCATTACCAAAATCCAAAAAATCTTCCAGCAAAGGTAGTAAAAAGGAACGGAACAGTTCTGGAACAACAAGGAAGTCAAAGCAAACTAAATGCCCTGAAATTCTGTCAGATGAGTCTAGTAGTGATGAAGATGAGAAGAAAAATAAGGAAGAGTCTTCGGAAGATGAAGAGAAAGAAAGTGAAGAGGAGCAACCACCAAA
Ensembl | mouse accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Gene Information
mouse ... DEK(110052), Dek(110052)
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Dong Lin et al.
Oncotarget, 6(3), 1806-1820 (2014-12-30)
Neuroendocrine prostate cancer (NEPC) is an aggressive subtype of prostate cancer which does not respond to hormone therapy. Research of NEPC has been hampered by a lack of clinically relevant in vivo models. Recently, we developed a first-in-field patient tissue-derived
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| EMU042071-20UG | 04061828487387 |
| EMU042071-50UG | 04061828262083 |